MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research

MS Risk in Children Born to Vitamin D Deficient Women

MStranslate
March 9, 2016
Lifestyle, Research, Vitamin D
Research Summary: Vitamin D Status During Pregnancy and Risk on Multiple Sclerosis in Women in the Finnish Maternity Cohort The background Many studies have suggested that vitamin D deficiency is...

Embracing Crowdfunding to Grow MStranslate

MStranslate
March 7, 2016
Community, Conferences, Research
At MStranslate, we pride ourselves on the quality of science communication that we provide to the international multiple sclerosis community. We believe that one of the aspects that makes us truly unique is...

Mesenchymal Stem Cell Trial for MS

MStranslate
February 22, 2016
Research, Stem Cells
1 Comment
INTERVIEW WITH DR VIOLAINE HARRIS – SENIOR RESEARCH SCIENTIST, TISCH MS RESEARCH CENTER BD: Brett Drummond, MStranslate VH: Dr Violaine Harris, Tisch MS Research...

Remyelination in MS: Novoron Bioscience

MStranslate
January 28, 2016
Dr Travis Stiles, Remyelination, Research, Treatments
INTERVIEW WITH DR TRAVIS STILES – CEO, NOVORON BIOSCIENCE BD: Brett Drummond, MStranslate TS: Dr Travis Stiles, Novoron Bioscience BD:  So welcome everyone to our video today.  This video has come...

Melatonin improves outcomes in mouse model of MS

MStranslate
January 12, 2016
Research, Treatments
Research Summary: Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis The...

Female Sex Hormones & Multiple Sclerosis

MStranslate
January 8, 2016
Hormones, Research
It has been known for a while that women are more likely to develop multiple sclerosis than men.  There have been many studies that have indicated that this may be related to female sex hormones.  For...

Effects of High-Dose Vitamin D in PwMS

MStranslate
January 4, 2016
Lifestyle, Research, Vitamin D
Research Summary: Safety and immunologic effects of high- and low-dose cholecalciferol in MS The background There is growing evidence to implicate a potential role for Vitamin D in the development and...

Spinal Cord Lesions & The Risk of Relapse

MStranslate
December 14, 2015
Neuroimaging, Research
Research Summary: Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis The background Magnetic resonance imaging or MRI has become a common tool for the diagnosis of multiple...

Neuroprotection by Novel T Cell Enzyme Inhibitor

MStranslate
December 9, 2015
Research, Treatments
Research Summary: Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo The background Previous studies have shown that immune cells, known as cytotoxic T cells, are critical in the...

Statement on HSCT for MS: Professor Eva Havrdova

MStranslate
December 7, 2015
Research, Stem Cells, Treatments
Professor Eva Havrdova from Charles University in Prague presented at the recent ECTRIMS Congress, where she discussed the use of Hematopoietic Stem Cell Transplantation (HSCT) for the treatment of multiple...
  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21

Recent Posts

  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Apr    

Archives

Categories

Posts

  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.